4-Methylmorpholine → HCID 20610777, compound
Reaction equation
[C:1]([N:12]1[C@@H:16]([CH3:17])[C:15](=[O:18])OC1=O)(=[O:11])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH3:10].[C:20]1([CH3:29])[CH:25]=[CH:24][C:23]([C@@H:26]([NH2:28])[CH3:27])=[CH:22][CH:21]=1.CN1CCOCC1>O1CCCC1>[C:20]1([CH3:29])[CH:25]=[CH:24][C:23]([C@@H:26]([NH:28][C:15](=[O:18])[C@H:16]([CH3:17])[NH:12][C:1](=[O:11])[CH2:2][CH2:3][CH2:4][CH2:5][CH2:6][CH2:7][CH2:8][CH2:9][CH3:10])[CH3:27])=[CH:22][CH:21]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
(S)-3-Decanoyl-4-methyl-2,5-oxazolidinedione (N-decanoyl-L-alanine-NCA) (100 mg, 0.37 mmol) was dissolved in tetrahydrofuran (3 mL), and at 0° C., (S)-1-(p-tolyl)ethylamine (49 mg, 0.36 mmol) and N-methylmorpholine (37 mg, 0.36 mmol) were added, followed by stirring for 30 minutes. The reaction mixture was treated in a similar manner as in Example 19 to afford the title compound (103 mg, 77%) as white crystals.
Workup
- additionThe reaction mixture was treated in a similar manner as in Example 19
Sources & evidence
- ORD record
- ord-ff9a37867cfe4921a44facf0b2b59abc
- Source dataset
- uspto-grants-2003_12
- Patent number
- US06670447B2
Reaction notes
Loading…